ROYCE & ASSOCIATES LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$653,000
+10.7%
69,057
+4.9%
0.01%
+16.7%
Q2 2020$590,000
+40.8%
65,8150.0%0.01%0.0%
Q1 2020$419,000
-24.0%
65,8150.0%0.01%
+20.0%
Q4 2019$551,000
-7.6%
65,8150.0%0.01%
-16.7%
Q3 2019$596,000
-15.9%
65,8150.0%0.01%0.0%
Q2 2019$709,000
+12.9%
65,8150.0%0.01%
+20.0%
Q1 2019$628,000
-37.0%
65,815
-24.2%
0.01%
-44.4%
Q4 2018$997,000
-58.2%
86,815
-38.3%
0.01%
-43.8%
Q3 2018$2,387,000
-34.3%
140,815
-45.0%
0.02%
-36.0%
Q2 2018$3,633,000
+3.5%
255,815
+38.5%
0.02%0.0%
Q1 2018$3,509,000
-35.4%
184,665
-44.2%
0.02%
-30.6%
Q4 2017$5,428,000
-24.4%
330,965
-30.8%
0.04%
-25.0%
Q3 2017$7,177,000
+8.6%
478,465
-36.3%
0.05%
+9.1%
Q2 2017$6,610,000
+69.2%
751,1000.0%0.04%
+69.2%
Q1 2017$3,906,000
+70.5%
751,1000.0%0.03%
+73.3%
Q4 2016$2,291,000
-7.7%
751,100
+40.1%
0.02%
-6.2%
Q3 2016$2,482,000
-6.0%
536,100
+17.5%
0.02%
-5.9%
Q2 2016$2,641,000
-4.3%
456,1000.0%0.02%0.0%
Q1 2016$2,759,000
-3.2%
456,100
+46.1%
0.02%0.0%
Q4 2015$2,849,000
+138.2%
312,100
+47.1%
0.02%
+183.3%
Q3 2015$1,196,000212,1000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders